Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot O75695: Variant p.Cys108Tyr

Protein XRP2
Gene: RP2
Feedback?
Variant information Variant position: help 108 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Cysteine (C) to Tyrosine (Y) at position 108 (C108Y, p.Cys108Tyr). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and polar (C) to large size and aromatic (Y) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In RP2. Any additional useful information about the variant.


Sequence information Variant position: help 108 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 350 The length of the canonical sequence.
Location on the sequence: help NCIIFLGPVKGSVFFRNCRD C KCTLACQQFRVRDCRKLEVF The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         NCIIFLGPVKGSVFFRNCRDCKCTLACQQFRVRDCRKLEVF

Mouse                         NCVIFLGPVKGSVFFRNCRDCKCTLACQQFRVRDCRKLEVF

Chicken                       NCQIFLGPIKGSVFFRNCKDCKCIVACQQFRTRDCRRLEVF

Xenopus laevis                NCRIFLGPVKGSVFFRDCKDCKCVVACQQFRTRDCRRMDVF

Zebrafish                     NCRIVLGPVKGSVFFRDCKDIKCVVACQQFRTRDCKKMDVF
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 2 – 350 Protein XRP2
Domain 24 – 179 C-CAP/cofactor C-like
Mutagenesis 101 – 101 F -> A. Reduces affinity for mouse ARL3.
Mutagenesis 115 – 115 Q -> A. Reduces affinity for mouse ARL3.
Mutagenesis 116 – 116 Q -> A. Reduces affinity and GTP-hydrolysis rate for mouse ARL3.
Mutagenesis 118 – 118 R -> A. Reduces affinity and GTP-hydrolysis rate for mouse ARL3.
Mutagenesis 120 – 120 R -> H. Reduces affinity for mouse ARL3; when associated with S-121.
Mutagenesis 121 – 121 D -> S. Reduces affinity for mouse ARL3; when associated with H-120.
Beta strand 106 – 121



Literature citations
Next-generation genetic testing for retinitis pigmentosa.
Neveling K.; Collin R.W.; Gilissen C.; van Huet R.A.; Visser L.; Kwint M.P.; Gijsen S.J.; Zonneveld M.N.; Wieskamp N.; de Ligt J.; Siemiatkowska A.M.; Hoefsloot L.H.; Buckley M.F.; Kellner U.; Branham K.E.; den Hollander A.I.; Hoischen A.; Hoyng C.; Klevering B.J.; van den Born L.I.; Veltman J.A.; Cremers F.P.; Scheffer H.;
Hum. Mutat. 33:963-972(2012)
Cited for: VARIANT RP2 TYR-108;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.